Scientists suggest fresh look at psychedelic drugs
Scientists suggest fresh look at psychedelic drugs - Aug 2010
Combined with therapy, such substances could treat depression, chronic pain
LONDON ? Mind-altering drugs like LSD, ketamine or magic mushrooms could be combined with psychotherapy to treat people suffering from depression, compulsive disorders or chronic pain, Swiss scientists suggested on Wednesday. Research into the effects of psychedelics, used in the past in psychiatry, has been restricted in recent decades because of the negative connotations of drugs, but the scientists said more studies into their clinical potential were now justified.
The researchers said recent brain imaging studies show that psychedelics such as lysergic acid diethylamide (LSD), ketamine and psilocybin ? the psychoactive component in recreational drugs known as magic mushrooms ? act on the brain in ways that could help reduce symptoms of various psychiatric disorders. The drugs could be used as a kind of catalyst, the scientists said, helping patients to alter their perception of problems or pain levels and then work with behavioral therapists or psychotherapists to tackle them in new ways.
"Psychedelics can give patients a new perspective ? particularly when things like suppressed memories come up ? and then they can work with that experience," said Franz Vollenweider of the Neuropsychopharmacology and brain imaging unit at Zurich's University Hospital of Psychiatry, who published a paper on the issue in Nature Neuroscience journal. Depending on the type of person taking the drug, the dose and the situation, psychedelics can have a wide range of effects, experts say, from feelings of boundlessness and bliss at one end of the spectrum to anxiety-inducing feelings of loss of control and panic at the other.
FULL LINK
Anxiously looking forward to the glorious return of LSD to the forefront. 
Combined with therapy, such substances could treat depression, chronic pain
LONDON ? Mind-altering drugs like LSD, ketamine or magic mushrooms could be combined with psychotherapy to treat people suffering from depression, compulsive disorders or chronic pain, Swiss scientists suggested on Wednesday. Research into the effects of psychedelics, used in the past in psychiatry, has been restricted in recent decades because of the negative connotations of drugs, but the scientists said more studies into their clinical potential were now justified.
The researchers said recent brain imaging studies show that psychedelics such as lysergic acid diethylamide (LSD), ketamine and psilocybin ? the psychoactive component in recreational drugs known as magic mushrooms ? act on the brain in ways that could help reduce symptoms of various psychiatric disorders. The drugs could be used as a kind of catalyst, the scientists said, helping patients to alter their perception of problems or pain levels and then work with behavioral therapists or psychotherapists to tackle them in new ways.
"Psychedelics can give patients a new perspective ? particularly when things like suppressed memories come up ? and then they can work with that experience," said Franz Vollenweider of the Neuropsychopharmacology and brain imaging unit at Zurich's University Hospital of Psychiatry, who published a paper on the issue in Nature Neuroscience journal. Depending on the type of person taking the drug, the dose and the situation, psychedelics can have a wide range of effects, experts say, from feelings of boundlessness and bliss at one end of the spectrum to anxiety-inducing feelings of loss of control and panic at the other.
FULL LINK
Anxiously looking forward to the glorious return of LSD to the forefront.
Comment